Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation

Endocrinology

Volumn 140, Issue 9, 1999, Pages 4351-4358

  Hägglund, Anna Carin ^a   Ny, Annelii ^a   Leonardsson, Göran ^a   Ny, Tor ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; FEMALE; HORMONAL REGULATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; OVARY; OVULATION; PRIORITY JOURNAL; RNA ANALYSIS; TISSUE DISTRIBUTION;

EID: 0033305408     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.9.7002     Document Type: Article

References (50)

1. Extracellular matrix degradation
2. Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitors
3. The biochemistry of cancer dissemination
4. Proteolytic remodeling of extracellular matrix
5. Extracellular matrix remodeling by metalloproteinases and plasminogen activators
6. Matrix metalloproteinases and the development of cancer
7. An analysis of follicle development and ovum maturation
8. Mechanism of mammalian ovulation
9. Hormonal regulation of the fibrinolytic components in the ovary
10. Ovarian plasminogen activator: Relationship to ovulation and hormonal regulation
11. The role of collagenase in ovulation in the rat
12. Tissue-specific and time-coordinated hormone regulation of plasminogen-activator-inhibitor type I and tissue-type plasminogen activator in the rat ovary during gonadotropin-induced ovulation
13. Gelatinase and proteoglycanase activity during the periovulatory period in the rat
14. Transient and cell-specific expression of tissue-type plasminogen activator and plasminogen-activator-inhibitor type 1 results in controlled and directed proteolysis during gonadotropin-induced ovulation
15. Follicular plasminogen activator: Involvement in ovulation
16. 2-antiplasmin
17. Inhibitors of mammalian tissue collagenase and metalloproteinases suppress ovulation in the perfused rat ovary
18. Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC 44463
19. Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: Functional redundancy among physiological plasminogen activators
20. Collagenase 2 (MMP-8) expression in murine tissue-remodeling processes. Analysis of its potential role in postpartum involution of the uterus
21. A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: Evidence for inducible and constitutive transcripts
22. Cloning and sequencing of the cDNA encoding a mouse tissue inhibitor of metalloproteinase-2
23. Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development
24. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development
25. Cloning and sequencing of mouse collagenase cDNA. Divergence of mouse and rat collagenases from the other mammalian collagenases
26. Cloning and sequencing of a cDNA encoding mouse stromelysin 1
27. cDNA cloning and expression of the gene encoding murine stromelysin-2 (MMP-10)
28. The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis
29. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas
30. The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse
31. Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase
32. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues
33. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution
34. A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: In situ hybridization using digoxigenin-labelled cRNA probes
35. Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation
36. Human skin fibroblast procollagenase: Mechanisms of activation by organomercurials and trypsin
37. Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate
38. Expression of collagenase-3 in the rat ovary during the ovulatory process
39. A matrix metalloproteinase expressed on the surface of invasive tumour cells
40. Activation mechanisms of matrix metalloproteinases
41. Tumor cell interactions with the extracellular matrix during invasion and metastasis
42. Ovulation as a tissue remodelling process: Proteolysis and cumulus expansion
43. Types I and IV collagenolytic and plasminogen activator activities in preovulatory ovarian follicles
44. In vivo measurement of rat ovarian collagenolytic activities
45. Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid: Role of eicosanoids
46. The involvement of collagenolysis in ovulation in the rat
47. Coordinated and cell-specific regulation of membrane type matrix metalloproteinase 1 (MT1-MMP) and matrix metalloproteinase 2 (MMP-2) by physiological signals during follicular development and ovulation
48. Transcriptional activation of the matrix metalloproteinase gene stromelysin-3 coincides with thyroid hormone-induced cell death during frog metamorphosis
49. Developmental expression of mouse stromelysin-3 mRNA
50. Localization of preovulatory expression of plasminogen activator inhibitor type-1 and tissue inhibitor of metalloproteinase type-1 mRNAs in the rat ovary